Keeping the Promises of Early Discovery Through the CDx Development Stages
Time: 12:40 pm
day: Day 2 Track C AM
Details:
- Successfully delivering co-commercialisation & full sample journey traceability across global CDx launch.
- Optimizing the IVD journey from RUO to CTA and CDx delivery to ensure assay robustness and effective CDx use
- Stemming from targeted biomarker selection processes through consecutive exploratory rounds, highlighting how advanced technologies contribute to effective downstream project delivery.
- Exploring the relevance of large-scale biomarker screening to accelerate translational developments of targeted Biomarker signatures for new therapies in selected cohorts.
